Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Selley

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2003
Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptorsChad M Thompson, Heidi Wojno, Elisabeth Greiner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2000
Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brainL J Sim-Selley, D E Selley, L J Vogt, et al.
Brain Research|July 19, 2011
Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamusMichelle R Hoot, Laura J Sim-Selley, Dana E Selley, et al.
British Journal of Pharmacology|August 20, 2010
Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposureJames J Burston, Jenny L Wiley, Abimbola A Craig, et al.
Biochemical Pharmacology|July 13, 2001
mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphineD E Selley, C C Cao, T Sexton, et al.
Neuropharmacology|September 13, 2011
Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbensLaura J Sim-Selley, Michael P Cassidy, Antonino Sparta, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2013
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cellsSean M Emery, Moureq R Alotaibi, Qing Tao, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2011
Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonistsYunyun Yuan, Orgil Elbegdorj, Jianyang Chen, et al.
Brain Research Bulletin|May 20, 2003
Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brainDana E Selley, J Taylor Herbert, Drake Morgan, et al.
RSC Medicinal Chemistry|January 22, 2021
Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimerBethany A Reinecke, Guifeng Kang, Yi Zheng, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2003
Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptorsChad M Thompson, Heidi Wojno, Elisabeth Greiner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2000
Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brainL J Sim-Selley, D E Selley, L J Vogt, et al.
Brain Research|July 19, 2011
Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamusMichelle R Hoot, Laura J Sim-Selley, Dana E Selley, et al.
British Journal of Pharmacology|August 20, 2010
Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposureJames J Burston, Jenny L Wiley, Abimbola A Craig, et al.
Biochemical Pharmacology|July 13, 2001
mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphineD E Selley, C C Cao, T Sexton, et al.
Neuropharmacology|September 13, 2011
Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbensLaura J Sim-Selley, Michael P Cassidy, Antonino Sparta, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 22, 2013
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cellsSean M Emery, Moureq R Alotaibi, Qing Tao, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2011
Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonistsYunyun Yuan, Orgil Elbegdorj, Jianyang Chen, et al.
Brain Research Bulletin|May 20, 2003
Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brainDana E Selley, J Taylor Herbert, Drake Morgan, et al.
RSC Medicinal Chemistry|January 22, 2021
Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimerBethany A Reinecke, Guifeng Kang, Yi Zheng, et al.
Pageof 15